COVID-19 booster dose: US FDA approves single dose use for all adults


As the global fight against the coronavirus pandemic advances, US regulators have paved the way for COVID-19 booster doses for all adults. This has expanded the government's campaign to increase security in view of the increasing cases of corona virus.


The US Food and Drug Administration (US FDA) on Friday extended its Emergency Use Authorization (EUA) for booster doses of Pfizer and Moderna's COVID-19 vaccines. Indicating that a single dose may be given to all adults over the age of 18 for at least six months after completion of the initial dosage.

Pfizer and Moderna announced the Food and Drug Administration (FDA) decision after at least 10 states began offering the booster to all adults. The move will correct the confusion surrounding the eligibility of booster doses.

However the Centers for Disease Control and Prevention (CDC) must agree to expand the Pfizer and Moderna boosters to healthy young adults as well. Its scientific advisers were set to debate later on Friday. If the CDC agrees, millions more Americans could get three doses of protection before the new year. Anyone who has received a single-dose of Johnson & Johnson may already have received a booster.


All anti-Covid-19 vaccines used in the US still provide strong protection against serious illness, including hospitalization and death, but protection against infection can diminish over time.

Previously, the government approved vaccine boosters from Pfizer and BioNTech, as well as the similar Moderna vaccine, only for vulnerable groups, including older Americans and people with chronic health problems. This step has been taken at a time when the cases of Kovid-19 have increased rapidly in the last two weeks, especially in the states where people are forced to stay indoors during the cold season.

"Streamlining eligibility criteria and making booster doses available to all individuals 18 years of age and older will also help clear up confusion about who can receive a booster dose," said FDA vaccine chief Dr. Peter Marks. And it will ensure that the booster dose is available to everyone who may need it."

Dr. Anthony Fauci, America's top health expert, said, "I don't know of any other vaccines and we want people not to have to be hospitalized." Pfizer and its German partner BioNTech argued that the booster was needed. Widespread dosages can help reduce infections over a significant period of time.

"In the current situation, we have no other way to control the epidemic without providing boosters to everyone," BioNtech CEO Ugur Sahin told reporters during a visit to Washington last week.